{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:35:07Z","timestamp":1789842907963,"version":"4.0.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Interstitial pneumonia is a group of pathologies affecting the pulmonary interstitium, characterized by interstitial fibrosis and extensive alveolar consolidation. This disease can extend to the surrounding blood vessels and pulmonary interstitium, sometimes affecting the entire lung, resulting in functional limitations, including restrictive ventilatory defect, impaired gas exchange, and hypoxemia. Severe interstitial pneumonia can lead to death. Antitumor drugs can induce interstitial pneumonia. Sintilimab is an immune checkpoint inhibitor, a recombinant fully human immunoglobulin G-type programmed death protein-1 monoclonal antibody inhibitor. S-1 is a compound preparation consisting of gimeracil, oteracil potassium, and ftorafur. There have been cases of interstitial pneumonia caused by treatment with sintilimab or S-1 in clinical settings, but no cases of interstitial pneumonia caused by treatment with a combination of sintilimab and S-1 have been reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case report<\/jats:title><jats:p>A patient diagnosed with gastric cancer underwent nine courses of treatment using a chemotherapy regimen of combined oxaliplatin S-1., Due to severe bone marrow suppression and gastrointestinal adverse reactions, the treatment was switched to sintilimab in combination with S-1therapy., This change resulted in the development of interstitial pneumonia, as revealed by non-contrast chest Computed Tomography scans. Following a review of blood test results and a multidisciplinary consultation, we suspect that the interstitial pneumonia may have been caused either by Sintilimab alone or by the combined effects of sintilimab and S-1. The treatment was discontinued, and after receiving adequate glucocorticoid therapy, the pulmonary lesions showed slight improvement.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This case provides a clinical reference, indicating that prior touse of sintilimab in combination with S-1 antitumor regimen, a comprehensive baseline assessment should be conducted, including blood routine examination, enzyme tests, and pulmonary imaging examination, with close monitoring of the patient\u2019s pulmonary condition. If drug-induced lung injury is suspected, the medication should be discontinued immediately, and appropriate treatment should be initiated promptly.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1508558","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T07:39:14Z","timestamp":1738741154000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["A case report: interstitial pneumonia following treatment of gastric cancer with sintilimab in combination with S-1"],"prefix":"10.3389","volume":"16","author":[{"given":"Pei","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanhui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1042\/CS20200331","article-title":"Mechanisms and clinical manifestations of cardiovascular toxicities associated with immune checkpoint inhibitors","volume":"135","author":"Baik","year":"2021","journal-title":"Clin. Sci. Lond."},{"key":"B2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3969\/j.issn.2096-3807.2024.06.051","article-title":"The value and accuracy analysis of high-resolution CT in the diagnosis of interstitial pneumonia","volume":"8","author":"Chen","year":"2024","journal-title":"J. Imaging Res. Med. Appl."},{"key":"B3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.19803\/j.1672-8629.20230445","article-title":"One case of interstitial pneumonia caused by serplulimab injection","volume":"21","author":"Chen","year":"2024","journal-title":"Chin. J. Pharmacovigil."},{"key":"B4","first-page":"56","article-title":"Acute interstitial pneumonia induced by tegafur gimeracil oteracil potassium capsule combined with docetaxel: a case report","volume":"3","author":"Hou","year":"2015","journal-title":"J. General Surg. Clin."},{"key":"B5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3969\/j.issn.1001-0270.2015.02.13","article-title":"The diagnostic value of high-resolution computed tomography in interstitial pneumonia","volume":"27","author":"Hu","year":"2015","journal-title":"Image Technol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3760\/cma.j.issn.1001-0939.2016.06.005","article-title":"Chinese expert consensus on the diagnosis and treatment of idiopathic pulmonary fibrosis","volume":"39","year":"2016","journal-title":"Chin. J. Tuberc. Respir. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.16808\/j.cnki.issn1003-7705.2019.10.044","article-title":"A case report on the treatment of systemic sclerosis complicated with interstitial pneumonia using integrated traditional Chinese and western medicine","volume":"35","author":"Jin","year":"2019","journal-title":"Hunan J. Traditional Chin. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3779\/j.issn.1009-3419.2014.01.09","article-title":"Tegafur gimeracil oteracil potassium capsule induced acute interstitial lung D ease: a case report","volume":"17","author":"Li","year":"2014","journal-title":"Chin. J. Lung Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3969\/j.issn.1672-5131.2022.04.015","article-title":"High-resolution CT findings of interstitial pneumonia and its prognostic value","volume":"20","author":"li","year":"2022","journal-title":"Chin. J. CT MRI"},{"key":"B10","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3969\/j.issn.1002-0101.2022.06.016","article-title":"Diagnosis and treatment of jo-1 antibody positive of interstitial pneumonia with ultrasonic technology","volume":"38","author":"Liang","year":"2022","journal-title":"Chin. J. Ultrasound Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.3969\/j.issn.1009-6663.2019.08.001","article-title":"Diagnostic contribution of bronchoalveolar lavage fluid cellular analysis and CD4+\/CD8+ in interstitial lung disease","volume":"24","author":"Lin","year":"2019","journal-title":"J. Clin. Pulm. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3969\/j.issn.1673-9701.2024.14.033","article-title":"Research progress on adverse events related to percutaneous coronary intervention and their countermeasures","volume":"62","author":"Liu","year":"2024","journal-title":"China Mod. Dr."},{"key":"B13","doi-asserted-by":"publisher","first-page":"698447","DOI":"10.3389\/fphar.2021.698447","article-title":"Case report: afatinib-induced interstitial pneumonia: experiences and lessons from two patients","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.15887\/j.cnki.13-1389\/r.2023.31.047","article-title":"Pharmacovigilance of a case of interstitial pneumonia caused by xindilimab","volume":"16","author":"Liu","year":"2023","journal-title":"Chin. J. Clin. Ration. Drug Use"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.19939\/j.cnki.1672-2809.2023.11.32","article-title":"Literature analysis of imatinib-induced interstitial pneumonia","volume":"20","author":"Ma","year":"2023","journal-title":"Drug Eval."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1177\/1078155219879496","article-title":"Development of pneumonitis after rituximab treatment in a patient with lymphoma","volume":"26","author":"Mert","year":"2020","journal-title":"J. Oncol. Pharm. Pract. official Publ. Int. Soc. Oncol. Pharm. Pract."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3969\/j.issn.1009-5519.2023.12.008","article-title":"Diagnostic value of transbronchial lung biopsy in nonreactive pneumonia","volume":"39","author":"Pu","year":"2023","journal-title":"J. Mod. Med. and Health"},{"key":"B18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3969\/j.issn.1674-1749.2024.02.028","article-title":"Canxiong tongbi decoction for the treatment of 41 cases of rheumatoid arthritis-associated interstitial lung disease with phlegm and blood stasis blocking collateral syndrome","volume":"17","author":"Shao","year":"2024","journal-title":"Glob. Tradit. Chin. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3969\/j.issn.1674-7402.2023.01.014","article-title":"A 20-year backtrack of imatinib in postoperative adjuvant therapy for gastrointestinal stromal tumors","volume":"15","author":"Shi","year":"2023","journal-title":"J. Dig. Oncol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3969\/j.issn.1004-4337.2022.07.011","article-title":"Clinical value of transbronchial cryobiopsy in the diagnosis and evaluation of patients with interstitial pneumonia","volume":"35","author":"Wang","year":"2022","journal-title":"J. Math. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3969\/j.issn.1002-1256.2023.04.013","article-title":"A cases of interstitial pneumonia induced during the treatment of diffuse large B-cell lymphoma by using Rituximab combined with CDOP regimen","volume":"44","author":"Wang","year":"2023","journal-title":"J. Qiqihar Med. Univ."},{"key":"B22","doi-asserted-by":"publisher","first-page":"301+304","DOI":"10.16281\/j.cnki.jocml.2016.02.077","article-title":"Evaluation of the therapeutic efficacy of glucocorticoids in the acute exacerbation of interstitial lung diseases","volume":"3","author":"Xiong","year":"2016","journal-title":"J. Clin. Med. Literature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3969\/j.issn.1000-7369.2024.05.009","article-title":"The impact of the method for dispersing the lungs, removing stasis, and resolving phlegm on pulmonary function and serum inflammatory cytokines in patients with interstitial pneumonia","volume":"45","author":"Xu","year":"2024","journal-title":"Shaanxi J. Traditional Chin. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.13455\/j.cnki.cjcor.2020.11.33","article-title":"Experience in treating three cases of interstitial pneumonia induced by gemcitabine","volume":"27","author":"Yang","year":"2020","journal-title":"Chin. J. Clin. Oncol. Rehabilitation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.3969\/j.issn.1007-9572.2017.00.229","article-title":"Severe interstitial lung disease induced by S-1: a case report and literature review","volume":"21","author":"Yang","year":"2018","journal-title":"Chin. General Pract."},{"key":"B26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3760\/cma.j.issn.1673-436X.2020.03.012","article-title":"Progresses of interstitial pneumonia with autoimmune features","volume":"40","author":"Yu","year":"2020","journal-title":"Int. J. Respir."},{"key":"B27","doi-asserted-by":"publisher","first-page":"594558","DOI":"10.3389\/fonc.2020.594558","article-title":"Sintilimab: a promising anti-tumor PD-1 antibody","volume":"10","author":"Zhang","year":"2020","journal-title":"Front. Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/crj.13483","article-title":"Safety and accuracy of transbronchial lung cryobiopsy in diagnosing desquamative interstitial pneumonia","volume":"16","author":"Zhao","year":"2022","journal-title":"Clin. Respir. J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3969\/j.issn.2096-3807.2023.01.040","article-title":"Study on the diagnostic value of high-resolution computed tomography in interstitial pneumonia associated with connective tissue disease","volume":"7","author":"Zhu","year":"2023","journal-title":"J. Imaging Res. Med. Appl."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1508558\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T07:39:37Z","timestamp":1738741177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1508558\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":29,"alternative-id":["10.3389\/fphar.2025.1508558"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1508558","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"article-number":"1508558"}}